Factors related to NT-proBNP values in haemodynamically stable patients with normal systolic function of the left ventricle;Faktory se vztahem k hodnotám NT-proBNP u hemodynamicky stabilnich pacientů s normélní systolickou funkcí levé komory

Vnitrni Lekarstvi

Volumn 54, Issue 2, 2008, Pages 150-155

  Vytiska, Miroslav ^a   Kala, P ^a   Klabenesova I ^b   Bocek O ^a   Jerabek P ^a   Neugebauer, P ^a   Poloczek, M ^a   Parenica J ^a   Ludka, O ^a   Spinar J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b Oddeleni Klinicke Biochemie   (Czech Republic)

Author keywords

Left ventricle; NT proBNP and age; Pulse pressure; Sex

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AORTA PRESSORECEPTOR; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PULSE PRESSURE;

AGED; AGED, 80 AND OVER; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR FUNCTION, LEFT;

EID: 41849106510     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Takayoshi T, Atsuyuki W, Keiko M et al. Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure: Prognostic Role of Plasma Brain Natriuretic Peptide Concentration in Patients With Chronic Symptomatic Left Ventricular Dysfunction. Circulation 1997; 96: 509-516.
2. Bay M, Kirk V, Parner J et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 2003; 89: 150-154.
3. Wright SP, Doughty RN, Pearl A et al. Plasma amino-terminal pr-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. J Am Coll Cardiol 2003; 42: 1793-1800.
4. Lainchbury JG, Campbell E, Frampton CM et al. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003; 42: 728-735.
5. Morrow DA, de Lemos JA, Sabatine MS et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI-18. J Am Coll Cardiol 2003; 41: 1264-1272.
6. De Lemos JA, Morrow DA, Bentley JH et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
7. Richards AM, Nicholls MG, Espiner EA et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-2792.
8. Anand IS, Fisher LD, Chiang YT et al. for the Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
9. Kucher N, Printzen G, Doernhoefer T et al. Low pr-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism. Circulation 2003; 107: 1576-1568.
10. ten Wolde M, Tulevski II, Mulder JWM et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 2003; 107: 2082-2084.
11. Gerber IL, Stewart R, Legget ME et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003; 107: 1884-1890.
12. Sutton TM, Stewart RAH, Gerber IL et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-2287.
13. Januzzi JL, Camargo CA, Anwaruddin S et al. N-terminal ProBNP for emergency evaluation for shortness of breath: the ProBNP investigation of dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol 2005; 95: 948-954.
14. Catherine MO. Textbook of clinical echocardiography. 3. ed. Elsevier, Sauders 2004, 541 s.
15. Rimarčík M. Štatistický navigátor [online]. 2007, http://rimarcik.com/navigator
16. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: molecular aspects. The European journal of heart failure 2004; 6: 261-268.
17. Luchner A, Stevens TL, Borgeson DD et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol Heart Circ Physiol 1998; 274: 1684-1689
18. Toshihiro T, Boerrigter G, Huntley BK et al. Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases. Circ Res 2002; 91: 1127-1134.
19. McKie PM, Rodeheffer RJ, Cataliotti A et al. Amino-Terminal pr-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure. Hypertension 2006; 47; 874-880.
20. Wang TJ, Larson MG, Levy D et al. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. N Engl J Med 2004; 350: 655-663.
21. Redfield MM, Rodeheffer RR et al. Plasma Brain Natriuretic Peptide Concentration: Impact of Age and Gender. J Am Coll Cardiol 2002; 40: 976-982.
22. Wang TJ, Larson MG, Keyes MJ et al. Association of Plasma Natriuretic Peptide Levels With Metabolic Risk Factors in Ambulatory Individuals. Circulation 2007; 115: 115-119.
23. Yamamoto K, Burnett JC Jr, Jougasaki M et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.
24. Minoru Y, Hirofumi T, Yutaka K. et al. B-Type Natriuretic Peptide and Arterial Stiffness in Healthy Japanese Men. AJH 2006; 19: 443-447.
25. Vytiska M, Kala P, Peciar M et al. Je zvýšený enddiastolický tlak v levé komoře u populace staršího vëku patologický? Vnitř Lék 2006; 52: 40-43.
26. Rodeheffer RJ. Measuring Plasma B-Type Natriuretic Peptide in Heart Failure Good to Go in 2004? J Am Coll Cardiol 2004; 44: 740-749.
27. Redfield MM, Rodeheffer RJ, Jacobsen SJ et al. Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction A Community-Based Study. Circulation 2004; 109: 3176-3181.
28. The SOLVD investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992; 327: 685-691.
29. Topol EJ et al. Textbook of Cardiovascular medicine 3rd. ed. Lippincott Williams & Wilkins 2006.